Advertisement
C21 Investments Inc.

C21 Investments Inc. Fundamental Analysis

CXXI.CNCNQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.35
$0.01(2.74%)
Canadian Market is Open · 11:04
Advertisement

C21 Investments Inc. Fundamental Analysis

C21 Investments Inc. (CXXI.CN) shows weak financial fundamentals with a PE ratio of -16.70, profit margin of -9.91%, and ROE of -11.98%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.56

Areas of Concern

ROE-11.98%
Operating Margin6.99%
Cash Position2.93%
We analyze CXXI.CN's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 3.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
3.7/100

We analyze CXXI.CN's fundamental strength across five key dimensions:

Efficiency Score

Weak

CXXI.CN struggles to generate sufficient returns from assets.

ROA > 10%
-5.83%

Valuation Score

Excellent

CXXI.CN trades at attractive valuation levels.

PE < 25
-16.70
PEG Ratio < 2
-0.56

Growth Score

Weak

CXXI.CN faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

CXXI.CN maintains a strong and stable balance sheet.

Debt/Equity < 1
0.41
Current Ratio > 1
1.30

Profitability Score

Weak

CXXI.CN struggles to sustain strong margins.

ROE > 15%
-1198.20%
Net Margin ≥ 15%
-9.91%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CXXI.CN Expensive or Cheap?

P/E Ratio

CXXI.CN trades at -16.70 times earnings. This suggests potential undervaluation.

-16.70

PEG Ratio

When adjusting for growth, CXXI.CN's PEG of -0.56 indicates potential undervaluation.

-0.56

Price to Book

The market values C21 Investments Inc. at 2.11 times its book value. This may indicate undervaluation.

2.11

EV/EBITDA

Enterprise value stands at 4.88 times EBITDA. This is generally considered low.

4.88

How Well Does CXXI.CN Make Money?

Net Profit Margin

For every $100 in sales, C21 Investments Inc. keeps $-9.91 as profit after all expenses.

-9.91%

Operating Margin

Core operations generate 6.99 in profit for every $100 in revenue, before interest and taxes.

6.99%

ROE

Management delivers $-11.98 in profit for every $100 of shareholder equity.

-11.98%

ROA

C21 Investments Inc. generates $-5.83 in profit for every $100 in assets, demonstrating efficient asset deployment.

-5.83%

Following the Money - Real Cash Generation

Operating Cash Flow

C21 Investments Inc. generates limited operating cash flow of $736.89K, signaling weaker underlying cash strength.

$736.89K

Free Cash Flow

C21 Investments Inc. produces free cash flow of $604.33K, offering steady but limited capital for shareholder returns and expansion.

$604.33K

FCF Per Share

Each share generates $0.01 in free cash annually.

$0.01

FCF Yield

CXXI.CN converts 3.78% of its market value into free cash.

3.78%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-16.70

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.56

vs 25 benchmark

P/B Ratio

Price to book value ratio

2.11

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.90

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.41

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.30

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.12

vs 25 benchmark

ROA

Return on assets percentage

-0.06

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How CXXI.CN Stacks Against Its Sector Peers

MetricCXXI.CN ValueSector AveragePerformance
P/E Ratio-16.7033.74 Better (Cheaper)
ROE-11.98%404.00% Weak
Net Margin-9.91%-40219.00% (disorted) Weak
Debt/Equity0.410.81 Strong (Low Leverage)
Current Ratio1.305.53 Neutral
ROA-5.83%-281.00% (disorted) Weak

CXXI.CN outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews C21 Investments Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ